Healthcare
Agilent Technologies Inc.(A)
Data coverage status · 6 need attention
Quote through 2026-08-05T13:30:00Z · Stale
Quote synced 2026-08-05T22:28:27.396107Z
Daily bars through 2026-08-04 · Delayed
Daily bars synced 2026-08-05T04:43:34.989679Z
Fundamentals through 2025-10-31 · Stale
Fundamentals synced 2026-08-05T21:39:46.20989Z
Forecasts: Stale
Forecasts synced 2026-05-05T11:53:49.765898Z
Ownership through 2025-10-31 · Stale
Ownership synced 2026-08-05T21:39:46.20989Z
Short interest through 2025-10-31 · Stale
Short interest synced 2026-08-05T21:39:46.20989Z
News through 2026-07-31T13:20:00Z · Stale
News synced 2026-08-02T07:26:53.664136Z
Company profile: Delayed
Company profile synced 2026-05-06T21:55:58.178672Z
Regular-session price
Offline$141.11
+1.37% regular session
1Y Change
+21.16%
Window
Aug 5, 2025 → Aug 4, 2026
- Market Cap
- $31.70B
- P/E
- 24.6
- Trailing
- 52W Range
- $108.35 - $160.27
- Volume
- 1.27M
- 0.4x RVOL
Investment Snapshot
Valuation, growth, profitability, catalysts, and benchmark context.
1D
+1.4%
1M
+6.6%
6M
+4.7%
YTD
+0.9%
1Y
+21.2%
- Market Cap
- $31.70B
- NYSE
- P/E
- 24.6
- Trailing valuation
- Revenue Growth
- +6.7%
- TTM growth
- EPS Growth
- +3.4%
- TTM earnings growth
- Operating Margin
- 21.3%
- TTM profitability
- Forward P/E
- —
- Waiting on consensus EPS
- Next Earnings
- Oct 1, 2026
- In 57 days
- 52W Position
- 63%
- $108.35 - $160.27
- Volume
- 0.4x
- 1.27M shares latest
- Benchmark
- -1.67 pts
- vs SPY over 1Y
- Dividend
- 0.7%
- Last ex-date Mar 31, 2026
Coverage: 250 bars · Aug 5, 2025 → Aug 4, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Agilent Technologies Inc. (A) is a Healthcare stock with listed on NYSE. The stock last traded around $141.11 and up 21.2% across the available one-year price window (Aug 5, 2025 → Aug 4, 2026). Baseline metrics include revenue growth of +6.7%, EPS growth of +3.4%, a dividend yield of 0.7%. What stands out right now is revenue +6.7%, EPS +3.4%, free cash flow -16.1% with operating margin 21.3% and ROIC 12.1%. The dividend is present but secondary, with a yield around 0.7%. Valuation sits in the middle of the pack at P/E 24.6 and price/sales 4.5. Stock Foundry combines A price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+6.7% vs +7.1% peer median
Operating Margin
Above sector median
+21.3% vs +10.1% peer median
P/E
Below sector median
24.6 vs 101.5 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report landed above expectations
Q3 2026 was reported on Jul 1, 2026 with an EPS surprise of +7.9%.
The operating story is still moving forward
Revenue is running at +6.7% and EPS at +3.4%, with operating margin around 21.3%.
The next real check-in already has a date
The next earnings event is scheduled for Oct 1, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +5.1% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS Delta | 1D | 5D | 20D |
|---|---|---|---|---|
Q3 2026 Jul 1, 2026 | +7.9% | -2.0% | +0.1% | +4.0% |
Q2 2026 May 27, 2026 | +5.7% | +16.9% | +18.6% | +17.0% |
Q1 2026 Feb 25, 2026 | -0.7% | -3.0% | -3.4% | -9.4% |
Benchmark Edge
A vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
A trails SPY
A is 1.67 pts behind over the shared 1Y window.
A had 20.74 pts deeper max drawdown than SPY.
A beat SPY in 1 of 2 calendar years shown and trailed in 1.
A
+21.16%
Normalized return
SPY
+22.83%
S&P 500
Excess Return
-1.67 pts
Relative to SPY
A Max Drawdown
-29.87%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for A and SPY.
| Year | A | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | +0.91% | +12.67% | -11.77 pts | SPY |
| 2025 | +19.78% | +9.40% | +10.38 pts | A |
Company Overview
Agilent Technologies, Inc.
New York Stock Exchange
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
- Leadership
- Padraig McDonnell
- IPO Date
- Nov 18, 1999
- Employees
- 17.9k
- Street Address
- 5301 Stevens Creek Boulevard
- Mailing
- Santa Clara, CA, 95051
- Region
- Santa Clara, CA, US
- Reporting Currency
- USD
- Investor Line
- 800 227 9770
- Last Updated
- May 6, 2026
Statistics & Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 24.6
- EV/EBITDA
- 18.3
- Price/Sales
- 4.5
- Price/Book
- 4.6
Growth
- Revenue
- +6.7%
- EPS
- +3.4%
- Free Cash Flow
- -16.1%
Profitability
- Gross Margin
- 52.4%
- Operating Margin
- 21.3%
- Net Margin
- 18.8%
- ROE
- 19.7%
- ROIC
- 12.1%
Balance Sheet
- Debt/Equity
- 0.49
- Current Ratio
- 0.77
Ownership & Float
- Float
- 281.47M
- Short Interest
- 2.3%
- Insider Owned
- 0.2%
- Institutional Owned
- 94.0%
Earnings Reports
Latest News
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.